The Procter Gamble Company

Peter J Maurer

Jeffrey Joseph Ares

Russell James Sheldon

Raymond Todd Henry

Thomas L Cupps

William Lee Seibel

Daniel P Walker

Sophie Eva Bogdan

Glen E Mieling

The subject invention relates to methods of treating alpha-2 adenoreceptor modulated disorders, comprising administration, to a mammal in need of such treatment, of a safe and effective amount of a compound having the following structure: ##STR1## wherein: (a) R is unsubstituted C.sub.1 -C.sub.3 alkanyl or alkenyl; and

6-(2-imidazolinylamino)quinoxaline compounds useful as alpha-2

The subject invention relates to compounds having the structure: ##STR1## wherein (a) n is an integer from 1 to about 3;

2-Imidazolinylamino heterocyclic compounds useful as alpha-2

2-imidazolinylamino heterocyclic compounds useful as alpha-2

The subject invention involves methods of treating nasal congestion comprising administration, to a human or lower animal in need of such treatment of a safe and effective amount of a compound having the following structure: ##STR1## wherein (a) R is unsubstituted C.sub.1 -C.sub.3 alkanyl or alkenyl; and

6-(2-imidazolinylamino) quinoxaline compounds useful as .alpha.-2

The subject invention relates to compounds having the structure: ##STR1## as defined in the claims, and to pharmaceutical compositions containing such compounds, and the use of such compounds for preventing or treating of disorders modulated by alpha-2 adrenoceptors.

6-(2-imidazolinylamino) quinolines useful as alpha-2 adrenoceptor

The subject invention relates to compounds having the structure: ##STR1## wherein: (a) R is unsubstituted C.sub.1 -C.sub.3 alkanyl or alkenyl;

Growing community of inventors

Cincinnati, OH, United States of America

Peter J Maurer